Παρασκευή 24 Μαρτίου 2017

FDA grants avelumab accelerated approval for Merkel cell carcinoma

The U.S. Food and Drug Administration has granted accelerated approval to avelumab for the treatment of adults and paediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oco7vZ
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις